Prevalence of acute kidney injury among dengue cases: a systematic review and meta-analysis

Bushi, Ganesh; Shabil, Muhammed; Padhi, Bijaya Kumar; Ahmed, Mohammed; Pandey, Pratima; Satapathy, Prakasini; Rustagi, Sarvesh; Pradhan, Keerti Bhusan; Al-qaim, Zahraa Haleem; Sah, Ranjit

doi:10.1093/trstmh/trad067

Cited by 16 publications

(5 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The data extracted covered the author’s name, year of publication, state/location of the study, study design, age and percentage of males in the sample, total number of HNC patients in the study, number of HPV-positive samples, and the type of test employed for detecting HPV. Quality assessment was done using a modified Newcastle-Ottawa Scale (NOS) version [ 22 , 23 ].…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence of human papillomavirus in head and neck cancer patients in India: a systematic review and meta-analysis

Satapathy,

Khatib,

Gaidhane

et al. 2024

BMC Infect Dis

Self Cite

View full text Add to dashboard Cite

Background Human papillomavirus (HPV) is increasingly recognized as a significant risk factor in the development of head and neck cancers (HNCs), with varying prevalence and impact. This study aims to systematically review and analyze the prevalence of HPV in HNCs in India, providing insights into regional variations. Methods A comprehensive literature search was carried out using PubMed, Embase, and Web of Science up to November 10, 2023. Inclusion criteria focused on original research reporting HPV-positive cases among HNC patients in India. We used Nested-Knowledge software, for screening, and data extraction. The modified Newcastle-Ottawa Scale was used for quality assessment of included studies. We pooled the prevalence of HPV among HNC patients and performed a random-effects model meta-analysis using R software (version 4.3). Results The search yielded 33 studies, encompassing 4654 HNC patients. The pooled prevalence of HPV infection was found to be 33% (95% CI: 25.8–42.6), with notable heterogeneity (I² = 95%). Analysis of subgroups according to geographical location indicated varying prevalence rates. Specifically, the prevalence was 47% (95% CI: 32.2–62.4) in the eastern regions and 19.8% (95% CI: 10.8–33.4) in the western regions. No evidence of publication bias was detected. Conclusion The observed considerable regional disparities on the prevalence of HPV in HNC patients in India emphasizes the need for integrated HPV vaccination and screening programs in public health strategies. The findings underline the necessity for further research to explore regional variations and treatment responses in HPV-associated HNCs, considering the impact of factors such as tobacco use and the potential benefits of HPV vaccination.

show abstract

Section: Methodsmentioning

confidence: 99%

“…The heterogeneity was further assessed using the 95% prediction interval. We calculated the tau-squared value using maximum likelihood estimation to gain additional insights into heterogeneity [ 25 – 28 ]. Subgroup analysis was conducted based on the location of the study.…”

Section: Methodsmentioning

confidence: 99%

Prevalence of human papillomavirus in head and neck cancer patients in India: a systematic review and meta-analysis

Satapathy,

Khatib,

Gaidhane

et al. 2024

BMC Infect Dis

Self Cite

View full text Add to dashboard Cite

show abstract

“…Data analysis was conducted using STATA version 17. Proportions, along with their 95% CIs, were pooled from all included eligible meta-analyses for each outcome and based on the population [ 21 ]. We used a random effects model to compute the combined effect sizes, recognizing the inherent variability among the studies and providing a more conservative estimate of the overall effect.…”

Section: Methodsmentioning

confidence: 99%

COVID-19 Vaccine Hesitancy: Umbrella Review of Systematic Reviews and Meta-Analysis

Rahbeni,

Satapathy,

Itumalla

et al. 2024

JMIR Public Health Surveill

Self Cite

View full text Add to dashboard Cite

Background The unprecedented emergence of the COVID-19 pandemic necessitated the development and global distribution of vaccines, making the understanding of global vaccine acceptance and hesitancy crucial to overcoming barriers to vaccination and achieving widespread immunization. Objective This umbrella review synthesizes findings from systematic reviews and meta-analyses to provide insights into global perceptions on COVID-19 vaccine acceptance and hesitancy across diverse populations and regions. Methods We conducted a literature search across major databases to identify systematic reviews and meta-analysis that reported COVID-19 vaccine acceptance and hesitancy. The AMSTAR-2 (A Measurement Tool to Assess Systematic Reviews) criteria were used to assess the methodological quality of included systematic reviews. Meta-analysis was performed using STATA 17 with a random effect model. The data synthesis is presented in a table format and via a narrative. Results Our inclusion criteria were met by 78 meta-analyses published between 2021 and 2023. Our analysis revealed a moderate vaccine acceptance rate of 63% (95% CI 0.60%-0.67%) in the general population, with significant heterogeneity (I2 = 97.59%). Higher acceptance rates were observed among health care workers and individuals with chronic diseases, at 64% (95% CI 0.57%-0.71%) and 69% (95% CI 0.61%-0.76%), respectively. However, lower acceptance was noted among pregnant women, at 48% (95% CI 0.42%-0.53%), and parents consenting for their children, at 61.29% (95% CI 0.56%-0.67%). The pooled vaccine hesitancy rate was 32% (95% CI 0.25%-0.39%) in the general population. The quality assessment revealed 19 high-quality, 38 moderate-quality, 15 low-quality, and 6 critically low-quality meta-analyses. Conclusions This review revealed the presence of vaccine hesitancy globally, emphasizing the necessity for population-specific, culturally sensitive interventions and clear, credible information dissemination to foster vaccine acceptance. The observed disparities accentuate the need for continuous research to understand evolving vaccine perceptions and to address the unique concerns and needs of diverse populations, thereby aiding in the formulation of effective and inclusive vaccination strategies. Trial Registration PROSPERO CRD42023468363; https://tinyurl.com/2p9kv9cr

show abstract

“…To evaluate the quality of the included studies, a modified version of the Newcastle‐Ottawa Scale was employed, with a scoring range from 0 to 6. This scale assessed the methodological rigor and potential bias of each study based on four criteria: representativeness (scored 0‐2), sample size (scored 0‐1), definition of infections (scored 0‐2), and ascertainment of HCV or HBV infections (scored 0‐1) 27,28 . A higher score indicated a higher level of methodological quality and a lower risk of bias in the respective study 29 …”

Section: Methodsmentioning

confidence: 99%

Prevalence of hepatitis B and C infections among HIV‐positive men who have sex with men: A systematic review and meta‐analysis

Shabil,

Yadav,

Shamim

et al. 2024

Health Science Reports

Self Cite

View full text Add to dashboard Cite

BackgroundHuman immunodeficiency virus (HIV) infection is highly prevalent and often coexists with other infectious diseases, especially Hepatitis B virus (HBV) and Hepatitis C virus (HCV). Men who have sex with men (MSM) represent a vulnerable population in terms of HIV infection. We aimed to determine the prevalence of HCV, HBV among HIV‐infected MSM.MethodsThis systematic review and meta‐analysis searched PubMed, Cochrane, Scopus, Web of Science, and ProQuest up‐to 2023/04/22. All studies reporting the prevalence of HBV or HCV infection in MSM PLHIV were included. Meta‐analysis used random effect model for synthesis and I2 along with prediction interval for heterogeneity. Subgroup analysis based on continent and meta‐regression for study size, average age and year of publication were used to explore heterogeneity. Modified Newcastle‐Ottawa Scale was used to evaluate the quality of studies according to the protocol (PROSPERO: CRD42023428764).ResultsFifty‐six of 5948 studies are included. In 53 studies with 3,07,589 participants, a pooled prevalence of 7% (95% confidence interval [CI]: 5–10) was found for HCV among MSM PLHIV, while a 9% (95% CI: 4–18) prevalence was found for HBV infection from five studies which included 5641 MSM PLHIV. Asia reported the lowest pooled prevalence at 5.84% (95% CI: 2.98–11.13) for HCV while Europe reported the highest pooled prevalence at 7.76% (95% CI: 4.35–13.45). Baujat plot and influence diagnostic identified contributors to influence and between‐study heterogeneity. Sensitivity analyses omitting these studies result in considerably more precise estimates. Another sensitivity analysis as leave‐one‐out meta‐analysis did not change any pooled estimate significantly.ConclusionThere is a significant burden of HCV and HBV among MSM PLHIV worldwide, with varying prevalence rates. Future studies should focus on these multimorbidity clusters and investigate factors influencing disease burden, long‐term outcomes, optimal testing strategies, and tailored interventions.

show abstract

Prevalence of acute kidney injury among dengue cases: a systematic review and meta-analysis

Cited by 16 publications

References 36 publications

Prevalence of human papillomavirus in head and neck cancer patients in India: a systematic review and meta-analysis

Prevalence of human papillomavirus in head and neck cancer patients in India: a systematic review and meta-analysis

COVID-19 Vaccine Hesitancy: Umbrella Review of Systematic Reviews and Meta-Analysis

Prevalence of hepatitis B and C infections among HIV‐positive men who have sex with men: A systematic review and meta‐analysis

Contact Info

Product

Resources

About